Global AI Drug Safety Prediction Software Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global AI Drug Safety Prediction Software market size was valued at US$ 422 million in 2025 and is forecast to a readjusted size of US$ 1735 million by 2032 with a CAGR of 22.5% during review period.
AI drug safety prediction software uses machine learning, deep learning, QSAR, expert rules, and physics-based models to predict absorption, distribution, metabolism, excretion, toxicity, drug-drug interactions, off-target effects, and safety pharmacology risks from molecular structures, experimental data, and curated knowledge bases. Typical functions include batch screening, applicability-domain and confidence assessment, explainability, custom model training, API or private deployment, and regulatory-ready reporting for drug discovery, preclinical research, and safety decision-making. The average gross margin is approximately 75%.
Demand mainly comes from pharmaceutical companies, biotechnology firms, CROs, and research institutions that are moving safety-risk screening earlier in development. The high cost of terminating candidates at later stages because of toxicity, pharmacokinetic, or drug-interaction liabilities encourages the use of computational prediction during hit screening, lead optimization, and candidate selection. Efforts to reduce animal testing, the expansion of virtual compound libraries, and broader regulatory use of new approach methodologies also support software adoption.
Product development is shifting from isolated QSAR endpoints toward combinations of multitask deep learning, expert knowledge, and physics-based simulation, with greater emphasis on applicability domains, confidence estimates, structural alerts, and analogue evidence. Established vendors retain advantages through curated toxicology databases, validated models, and regulatory workflows, while AI-native platforms are gaining adoption through faster computation, frequent model updates, and closed design-prediction loops. Purchasing decisions typically focus on endpoint coverage, external validation, proprietary-data model building, deployment security, system integration, and reporting compliance.
North America and Europe remain the leading commercial markets, while China and other Asian markets have strong potential because of expanding innovative-drug investment, local AI drug-discovery companies, and demand for private deployment. Opportunities include localization for regulatory requirements, enterprise-specific model training, multimodal safety assessment, and integration with experimental platforms. Key risks are training-data bias, unreliable predictions outside the applicability domain, limited coverage of biologics, and the continuing need for experimental confirmation and expert review.
Report Scope
This report is a detailed and comprehensive analysis for global AI Drug Safety Prediction Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Drug Safety Prediction Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Drug Safety Prediction Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI Drug Safety Prediction Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Safety Prediction Software, with revenue, gross margin, and global market share of AI Drug Safety Prediction Software from 2021 to 2026.
Chapter 3, the AI Drug Safety Prediction Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Safety Prediction Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Safety Prediction Software.
Chapter 13, to describe AI Drug Safety Prediction Software research findings and conclusion.
AI drug safety prediction software uses machine learning, deep learning, QSAR, expert rules, and physics-based models to predict absorption, distribution, metabolism, excretion, toxicity, drug-drug interactions, off-target effects, and safety pharmacology risks from molecular structures, experimental data, and curated knowledge bases. Typical functions include batch screening, applicability-domain and confidence assessment, explainability, custom model training, API or private deployment, and regulatory-ready reporting for drug discovery, preclinical research, and safety decision-making. The average gross margin is approximately 75%.
Demand mainly comes from pharmaceutical companies, biotechnology firms, CROs, and research institutions that are moving safety-risk screening earlier in development. The high cost of terminating candidates at later stages because of toxicity, pharmacokinetic, or drug-interaction liabilities encourages the use of computational prediction during hit screening, lead optimization, and candidate selection. Efforts to reduce animal testing, the expansion of virtual compound libraries, and broader regulatory use of new approach methodologies also support software adoption.
Product development is shifting from isolated QSAR endpoints toward combinations of multitask deep learning, expert knowledge, and physics-based simulation, with greater emphasis on applicability domains, confidence estimates, structural alerts, and analogue evidence. Established vendors retain advantages through curated toxicology databases, validated models, and regulatory workflows, while AI-native platforms are gaining adoption through faster computation, frequent model updates, and closed design-prediction loops. Purchasing decisions typically focus on endpoint coverage, external validation, proprietary-data model building, deployment security, system integration, and reporting compliance.
North America and Europe remain the leading commercial markets, while China and other Asian markets have strong potential because of expanding innovative-drug investment, local AI drug-discovery companies, and demand for private deployment. Opportunities include localization for regulatory requirements, enterprise-specific model training, multimodal safety assessment, and integration with experimental platforms. Key risks are training-data bias, unreliable predictions outside the applicability domain, limited coverage of biologics, and the continuing need for experimental confirmation and expert review.
Report Scope
This report is a detailed and comprehensive analysis for global AI Drug Safety Prediction Software market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI Drug Safety Prediction Software market size and forecasts, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global AI Drug Safety Prediction Software market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for AI Drug Safety Prediction Software
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
AI Drug Safety Prediction Software market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Integrated ADMET Prediction
- Toxicity Endpoint Prediction
- Drug-Drug Interaction and PK Safety Prediction
- Metabolism and Metabolite Prediction
- Off-Target and Safety Pharmacology Prediction
- Cloud-Based
- On-Premises
- Hybrid Deployment
- Machine Learning and Deep Learning
- QSAR and Statistical Modeling
- Knowledge-Based and Rule-Based
- Physics-Based Simulation
- Hybrid Modeling
- Fixed Pretrained Models
- User-Trained Models
- Hybrid Model Platforms
- Hit and Lead Screening
- Lead Optimization
- Candidate Selection
- Preclinical Safety Assessment
- Regulatory Safety Assessment
- Other Drug Safety Research
- Simulations Plus
- Dassault Syst?mes
- Schr?dinger
- Certara
- Lhasa Limited
- Instem
- ACD/Labs
- Chemical Computing Group
- Optibrium
- MultiCASE
- Insilico Medicine
- MindRank
- Molecular Discovery
- Molecular Networks
- OASIS LMC
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe AI Drug Safety Prediction Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Safety Prediction Software, with revenue, gross margin, and global market share of AI Drug Safety Prediction Software from 2021 to 2026.
Chapter 3, the AI Drug Safety Prediction Software competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and AI Drug Safety Prediction Software market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Safety Prediction Software.
Chapter 13, to describe AI Drug Safety Prediction Software research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Safety Prediction Software by Type
1.3.1 Overview: Global AI Drug Safety Prediction Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Type in 2025
1.3.3 Integrated ADMET Prediction
1.3.4 Toxicity Endpoint Prediction
1.3.5 Drug-Drug Interaction and PK Safety Prediction
1.3.6 Metabolism and Metabolite Prediction
1.3.7 Off-Target and Safety Pharmacology Prediction
1.4 Classification of AI Drug Safety Prediction Software by Deployment Model
1.4.1 Overview: Global AI Drug Safety Prediction Software Market Size by Deployment Model: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Deployment Model in 2025
1.4.3 Cloud-Based
1.4.4 On-Premises
1.4.5 Hybrid Deployment
1.5 Classification of AI Drug Safety Prediction Software by Modeling Approach
1.5.1 Overview: Global AI Drug Safety Prediction Software Market Size by Modeling Approach: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Modeling Approach in 2025
1.5.3 Machine Learning and Deep Learning
1.5.4 QSAR and Statistical Modeling
1.5.5 Knowledge-Based and Rule-Based
1.5.6 Physics-Based Simulation
1.5.7 Hybrid Modeling
1.6 Classification of AI Drug Safety Prediction Software by Model Customization
1.6.1 Overview: Global AI Drug Safety Prediction Software Market Size by Model Customization: 2021 Versus 2025 Versus 2032
1.6.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Model Customization in 2025
1.6.3 Fixed Pretrained Models
1.6.4 User-Trained Models
1.6.5 Hybrid Model Platforms
1.7 Global AI Drug Safety Prediction Software Market by Application
1.7.1 Overview: Global AI Drug Safety Prediction Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Hit and Lead Screening
1.7.3 Lead Optimization
1.7.4 Candidate Selection
1.7.5 Preclinical Safety Assessment
1.7.6 Regulatory Safety Assessment
1.7.7 Other Drug Safety Research
1.8 Global AI Drug Safety Prediction Software Market Size & Forecast
1.9 Global AI Drug Safety Prediction Software Market Size and Forecast by Region
1.9.1 Global AI Drug Safety Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global AI Drug Safety Prediction Software Market Size by Region, (2021-2032)
1.9.3 North America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.4 Europe AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.6 South America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Simulations Plus
2.1.1 Simulations Plus Details
2.1.2 Simulations Plus Major Business
2.1.3 Simulations Plus AI Drug Safety Prediction Software Product and Solutions
2.1.4 Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Simulations Plus Recent Developments and Future Plans
2.2 Dassault Syst?mes
2.2.1 Dassault Syst?mes Details
2.2.2 Dassault Syst?mes Major Business
2.2.3 Dassault Syst?mes AI Drug Safety Prediction Software Product and Solutions
2.2.4 Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Dassault Syst?mes Recent Developments and Future Plans
2.3 Schr?dinger
2.3.1 Schr?dinger Details
2.3.2 Schr?dinger Major Business
2.3.3 Schr?dinger AI Drug Safety Prediction Software Product and Solutions
2.3.4 Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Schr?dinger Recent Developments and Future Plans
2.4 Certara
2.4.1 Certara Details
2.4.2 Certara Major Business
2.4.3 Certara AI Drug Safety Prediction Software Product and Solutions
2.4.4 Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Certara Recent Developments and Future Plans
2.5 Lhasa Limited
2.5.1 Lhasa Limited Details
2.5.2 Lhasa Limited Major Business
2.5.3 Lhasa Limited AI Drug Safety Prediction Software Product and Solutions
2.5.4 Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Lhasa Limited Recent Developments and Future Plans
2.6 Instem
2.6.1 Instem Details
2.6.2 Instem Major Business
2.6.3 Instem AI Drug Safety Prediction Software Product and Solutions
2.6.4 Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Instem Recent Developments and Future Plans
2.7 ACD/Labs
2.7.1 ACD/Labs Details
2.7.2 ACD/Labs Major Business
2.7.3 ACD/Labs AI Drug Safety Prediction Software Product and Solutions
2.7.4 ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ACD/Labs Recent Developments and Future Plans
2.8 Chemical Computing Group
2.8.1 Chemical Computing Group Details
2.8.2 Chemical Computing Group Major Business
2.8.3 Chemical Computing Group AI Drug Safety Prediction Software Product and Solutions
2.8.4 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Chemical Computing Group Recent Developments and Future Plans
2.9 Optibrium
2.9.1 Optibrium Details
2.9.2 Optibrium Major Business
2.9.3 Optibrium AI Drug Safety Prediction Software Product and Solutions
2.9.4 Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Optibrium Recent Developments and Future Plans
2.10 MultiCASE
2.10.1 MultiCASE Details
2.10.2 MultiCASE Major Business
2.10.3 MultiCASE AI Drug Safety Prediction Software Product and Solutions
2.10.4 MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 MultiCASE Recent Developments and Future Plans
2.11 Insilico Medicine
2.11.1 Insilico Medicine Details
2.11.2 Insilico Medicine Major Business
2.11.3 Insilico Medicine AI Drug Safety Prediction Software Product and Solutions
2.11.4 Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Insilico Medicine Recent Developments and Future Plans
2.12 MindRank
2.12.1 MindRank Details
2.12.2 MindRank Major Business
2.12.3 MindRank AI Drug Safety Prediction Software Product and Solutions
2.12.4 MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 MindRank Recent Developments and Future Plans
2.13 Molecular Discovery
2.13.1 Molecular Discovery Details
2.13.2 Molecular Discovery Major Business
2.13.3 Molecular Discovery AI Drug Safety Prediction Software Product and Solutions
2.13.4 Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Molecular Discovery Recent Developments and Future Plans
2.14 Molecular Networks
2.14.1 Molecular Networks Details
2.14.2 Molecular Networks Major Business
2.14.3 Molecular Networks AI Drug Safety Prediction Software Product and Solutions
2.14.4 Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Molecular Networks Recent Developments and Future Plans
2.15 OASIS LMC
2.15.1 OASIS LMC Details
2.15.2 OASIS LMC Major Business
2.15.3 OASIS LMC AI Drug Safety Prediction Software Product and Solutions
2.15.4 OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 OASIS LMC Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Safety Prediction Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Drug Safety Prediction Software by Company Revenue
3.2.2 Top 3 AI Drug Safety Prediction Software Players Market Share in 2025
3.2.3 Top 6 AI Drug Safety Prediction Software Players Market Share in 2025
3.3 AI Drug Safety Prediction Software Market: Overall Company Footprint Analysis
3.3.1 AI Drug Safety Prediction Software Market: Region Footprint
3.3.2 AI Drug Safety Prediction Software Market: Company Product Type Footprint
3.3.3 AI Drug Safety Prediction Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Safety Prediction Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Drug Safety Prediction Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Drug Safety Prediction Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
6.2 North America AI Drug Safety Prediction Software Market Size by Application (2021-2032)
6.3 North America AI Drug Safety Prediction Software Market Size by Country
6.3.1 North America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
6.3.2 United States AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
6.3.3 Canada AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
7.2 Europe AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
7.3 Europe AI Drug Safety Prediction Software Market Size by Country
7.3.1 Europe AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
7.3.2 Germany AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.3 France AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.5 Russia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.6 Italy AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Drug Safety Prediction Software Market Size by Region
8.3.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2021-2032)
8.3.2 China AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.3 Japan AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.5 India AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.7 Australia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
9.2 South America AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
9.3 South America AI Drug Safety Prediction Software Market Size by Country
9.3.1 South America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Drug Safety Prediction Software Market Size by Country
10.3.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10.3.4 UAE AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Drug Safety Prediction Software Market Drivers
11.2 AI Drug Safety Prediction Software Market Restraints
11.3 AI Drug Safety Prediction Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Safety Prediction Software Industry Chain
12.2 AI Drug Safety Prediction Software Upstream Analysis
12.3 AI Drug Safety Prediction Software Midstream Analysis
12.4 AI Drug Safety Prediction Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Safety Prediction Software by Type
1.3.1 Overview: Global AI Drug Safety Prediction Software Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Type in 2025
1.3.3 Integrated ADMET Prediction
1.3.4 Toxicity Endpoint Prediction
1.3.5 Drug-Drug Interaction and PK Safety Prediction
1.3.6 Metabolism and Metabolite Prediction
1.3.7 Off-Target and Safety Pharmacology Prediction
1.4 Classification of AI Drug Safety Prediction Software by Deployment Model
1.4.1 Overview: Global AI Drug Safety Prediction Software Market Size by Deployment Model: 2021 Versus 2025 Versus 2032
1.4.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Deployment Model in 2025
1.4.3 Cloud-Based
1.4.4 On-Premises
1.4.5 Hybrid Deployment
1.5 Classification of AI Drug Safety Prediction Software by Modeling Approach
1.5.1 Overview: Global AI Drug Safety Prediction Software Market Size by Modeling Approach: 2021 Versus 2025 Versus 2032
1.5.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Modeling Approach in 2025
1.5.3 Machine Learning and Deep Learning
1.5.4 QSAR and Statistical Modeling
1.5.5 Knowledge-Based and Rule-Based
1.5.6 Physics-Based Simulation
1.5.7 Hybrid Modeling
1.6 Classification of AI Drug Safety Prediction Software by Model Customization
1.6.1 Overview: Global AI Drug Safety Prediction Software Market Size by Model Customization: 2021 Versus 2025 Versus 2032
1.6.2 Global AI Drug Safety Prediction Software Consumption Value Market Share by Model Customization in 2025
1.6.3 Fixed Pretrained Models
1.6.4 User-Trained Models
1.6.5 Hybrid Model Platforms
1.7 Global AI Drug Safety Prediction Software Market by Application
1.7.1 Overview: Global AI Drug Safety Prediction Software Market Size by Application: 2021 Versus 2025 Versus 2032
1.7.2 Hit and Lead Screening
1.7.3 Lead Optimization
1.7.4 Candidate Selection
1.7.5 Preclinical Safety Assessment
1.7.6 Regulatory Safety Assessment
1.7.7 Other Drug Safety Research
1.8 Global AI Drug Safety Prediction Software Market Size & Forecast
1.9 Global AI Drug Safety Prediction Software Market Size and Forecast by Region
1.9.1 Global AI Drug Safety Prediction Software Market Size by Region: 2021 VS 2025 VS 2032
1.9.2 Global AI Drug Safety Prediction Software Market Size by Region, (2021-2032)
1.9.3 North America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.4 Europe AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.5 Asia-Pacific AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.6 South America AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
1.9.7 Middle East & Africa AI Drug Safety Prediction Software Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Simulations Plus
2.1.1 Simulations Plus Details
2.1.2 Simulations Plus Major Business
2.1.3 Simulations Plus AI Drug Safety Prediction Software Product and Solutions
2.1.4 Simulations Plus AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Simulations Plus Recent Developments and Future Plans
2.2 Dassault Syst?mes
2.2.1 Dassault Syst?mes Details
2.2.2 Dassault Syst?mes Major Business
2.2.3 Dassault Syst?mes AI Drug Safety Prediction Software Product and Solutions
2.2.4 Dassault Syst?mes AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Dassault Syst?mes Recent Developments and Future Plans
2.3 Schr?dinger
2.3.1 Schr?dinger Details
2.3.2 Schr?dinger Major Business
2.3.3 Schr?dinger AI Drug Safety Prediction Software Product and Solutions
2.3.4 Schr?dinger AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Schr?dinger Recent Developments and Future Plans
2.4 Certara
2.4.1 Certara Details
2.4.2 Certara Major Business
2.4.3 Certara AI Drug Safety Prediction Software Product and Solutions
2.4.4 Certara AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Certara Recent Developments and Future Plans
2.5 Lhasa Limited
2.5.1 Lhasa Limited Details
2.5.2 Lhasa Limited Major Business
2.5.3 Lhasa Limited AI Drug Safety Prediction Software Product and Solutions
2.5.4 Lhasa Limited AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Lhasa Limited Recent Developments and Future Plans
2.6 Instem
2.6.1 Instem Details
2.6.2 Instem Major Business
2.6.3 Instem AI Drug Safety Prediction Software Product and Solutions
2.6.4 Instem AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Instem Recent Developments and Future Plans
2.7 ACD/Labs
2.7.1 ACD/Labs Details
2.7.2 ACD/Labs Major Business
2.7.3 ACD/Labs AI Drug Safety Prediction Software Product and Solutions
2.7.4 ACD/Labs AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 ACD/Labs Recent Developments and Future Plans
2.8 Chemical Computing Group
2.8.1 Chemical Computing Group Details
2.8.2 Chemical Computing Group Major Business
2.8.3 Chemical Computing Group AI Drug Safety Prediction Software Product and Solutions
2.8.4 Chemical Computing Group AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Chemical Computing Group Recent Developments and Future Plans
2.9 Optibrium
2.9.1 Optibrium Details
2.9.2 Optibrium Major Business
2.9.3 Optibrium AI Drug Safety Prediction Software Product and Solutions
2.9.4 Optibrium AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Optibrium Recent Developments and Future Plans
2.10 MultiCASE
2.10.1 MultiCASE Details
2.10.2 MultiCASE Major Business
2.10.3 MultiCASE AI Drug Safety Prediction Software Product and Solutions
2.10.4 MultiCASE AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 MultiCASE Recent Developments and Future Plans
2.11 Insilico Medicine
2.11.1 Insilico Medicine Details
2.11.2 Insilico Medicine Major Business
2.11.3 Insilico Medicine AI Drug Safety Prediction Software Product and Solutions
2.11.4 Insilico Medicine AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Insilico Medicine Recent Developments and Future Plans
2.12 MindRank
2.12.1 MindRank Details
2.12.2 MindRank Major Business
2.12.3 MindRank AI Drug Safety Prediction Software Product and Solutions
2.12.4 MindRank AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 MindRank Recent Developments and Future Plans
2.13 Molecular Discovery
2.13.1 Molecular Discovery Details
2.13.2 Molecular Discovery Major Business
2.13.3 Molecular Discovery AI Drug Safety Prediction Software Product and Solutions
2.13.4 Molecular Discovery AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Molecular Discovery Recent Developments and Future Plans
2.14 Molecular Networks
2.14.1 Molecular Networks Details
2.14.2 Molecular Networks Major Business
2.14.3 Molecular Networks AI Drug Safety Prediction Software Product and Solutions
2.14.4 Molecular Networks AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Molecular Networks Recent Developments and Future Plans
2.15 OASIS LMC
2.15.1 OASIS LMC Details
2.15.2 OASIS LMC Major Business
2.15.3 OASIS LMC AI Drug Safety Prediction Software Product and Solutions
2.15.4 OASIS LMC AI Drug Safety Prediction Software Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 OASIS LMC Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Safety Prediction Software Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of AI Drug Safety Prediction Software by Company Revenue
3.2.2 Top 3 AI Drug Safety Prediction Software Players Market Share in 2025
3.2.3 Top 6 AI Drug Safety Prediction Software Players Market Share in 2025
3.3 AI Drug Safety Prediction Software Market: Overall Company Footprint Analysis
3.3.1 AI Drug Safety Prediction Software Market: Region Footprint
3.3.2 AI Drug Safety Prediction Software Market: Company Product Type Footprint
3.3.3 AI Drug Safety Prediction Software Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Safety Prediction Software Consumption Value and Market Share by Type (2021-2026)
4.2 Global AI Drug Safety Prediction Software Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2026)
5.2 Global AI Drug Safety Prediction Software Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
6.2 North America AI Drug Safety Prediction Software Market Size by Application (2021-2032)
6.3 North America AI Drug Safety Prediction Software Market Size by Country
6.3.1 North America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
6.3.2 United States AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
6.3.3 Canada AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
6.3.4 Mexico AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
7.2 Europe AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
7.3 Europe AI Drug Safety Prediction Software Market Size by Country
7.3.1 Europe AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
7.3.2 Germany AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.3 France AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.4 United Kingdom AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.5 Russia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
7.3.6 Italy AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
8.2 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
8.3 Asia-Pacific AI Drug Safety Prediction Software Market Size by Region
8.3.1 Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2021-2032)
8.3.2 China AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.3 Japan AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.4 South Korea AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.5 India AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
8.3.7 Australia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
9.2 South America AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
9.3 South America AI Drug Safety Prediction Software Market Size by Country
9.3.1 South America AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
9.3.2 Brazil AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
9.3.3 Argentina AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2021-2032)
10.2 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2021-2032)
10.3 Middle East & Africa AI Drug Safety Prediction Software Market Size by Country
10.3.1 Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2021-2032)
10.3.2 Turkey AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
10.3.4 UAE AI Drug Safety Prediction Software Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 AI Drug Safety Prediction Software Market Drivers
11.2 AI Drug Safety Prediction Software Market Restraints
11.3 AI Drug Safety Prediction Software Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Safety Prediction Software Industry Chain
12.2 AI Drug Safety Prediction Software Upstream Analysis
12.3 AI Drug Safety Prediction Software Midstream Analysis
12.4 AI Drug Safety Prediction Software Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Drug Safety Prediction Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Drug Safety Prediction Software Consumption Value by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Drug Safety Prediction Software Consumption Value by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Drug Safety Prediction Software Consumption Value by Model Customization, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Drug Safety Prediction Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global AI Drug Safety Prediction Software Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Simulations Plus Company Information, Head Office, and Major Competitors
Table 9. Simulations Plus Major Business
Table 10. Simulations Plus AI Drug Safety Prediction Software Product and Solutions
Table 11. Simulations Plus AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Simulations Plus Recent Developments and Future Plans
Table 13. Dassault Syst?mes Company Information, Head Office, and Major Competitors
Table 14. Dassault Syst?mes Major Business
Table 15. Dassault Syst?mes AI Drug Safety Prediction Software Product and Solutions
Table 16. Dassault Syst?mes AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Dassault Syst?mes Recent Developments and Future Plans
Table 18. Schr?dinger Company Information, Head Office, and Major Competitors
Table 19. Schr?dinger Major Business
Table 20. Schr?dinger AI Drug Safety Prediction Software Product and Solutions
Table 21. Schr?dinger AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Certara Company Information, Head Office, and Major Competitors
Table 23. Certara Major Business
Table 24. Certara AI Drug Safety Prediction Software Product and Solutions
Table 25. Certara AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Certara Recent Developments and Future Plans
Table 27. Lhasa Limited Company Information, Head Office, and Major Competitors
Table 28. Lhasa Limited Major Business
Table 29. Lhasa Limited AI Drug Safety Prediction Software Product and Solutions
Table 30. Lhasa Limited AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Lhasa Limited Recent Developments and Future Plans
Table 32. Instem Company Information, Head Office, and Major Competitors
Table 33. Instem Major Business
Table 34. Instem AI Drug Safety Prediction Software Product and Solutions
Table 35. Instem AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Instem Recent Developments and Future Plans
Table 37. ACD/Labs Company Information, Head Office, and Major Competitors
Table 38. ACD/Labs Major Business
Table 39. ACD/Labs AI Drug Safety Prediction Software Product and Solutions
Table 40. ACD/Labs AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. ACD/Labs Recent Developments and Future Plans
Table 42. Chemical Computing Group Company Information, Head Office, and Major Competitors
Table 43. Chemical Computing Group Major Business
Table 44. Chemical Computing Group AI Drug Safety Prediction Software Product and Solutions
Table 45. Chemical Computing Group AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Chemical Computing Group Recent Developments and Future Plans
Table 47. Optibrium Company Information, Head Office, and Major Competitors
Table 48. Optibrium Major Business
Table 49. Optibrium AI Drug Safety Prediction Software Product and Solutions
Table 50. Optibrium AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Optibrium Recent Developments and Future Plans
Table 52. MultiCASE Company Information, Head Office, and Major Competitors
Table 53. MultiCASE Major Business
Table 54. MultiCASE AI Drug Safety Prediction Software Product and Solutions
Table 55. MultiCASE AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. MultiCASE Recent Developments and Future Plans
Table 57. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 58. Insilico Medicine Major Business
Table 59. Insilico Medicine AI Drug Safety Prediction Software Product and Solutions
Table 60. Insilico Medicine AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Insilico Medicine Recent Developments and Future Plans
Table 62. MindRank Company Information, Head Office, and Major Competitors
Table 63. MindRank Major Business
Table 64. MindRank AI Drug Safety Prediction Software Product and Solutions
Table 65. MindRank AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. MindRank Recent Developments and Future Plans
Table 67. Molecular Discovery Company Information, Head Office, and Major Competitors
Table 68. Molecular Discovery Major Business
Table 69. Molecular Discovery AI Drug Safety Prediction Software Product and Solutions
Table 70. Molecular Discovery AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Molecular Discovery Recent Developments and Future Plans
Table 72. Molecular Networks Company Information, Head Office, and Major Competitors
Table 73. Molecular Networks Major Business
Table 74. Molecular Networks AI Drug Safety Prediction Software Product and Solutions
Table 75. Molecular Networks AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. Molecular Networks Recent Developments and Future Plans
Table 77. OASIS LMC Company Information, Head Office, and Major Competitors
Table 78. OASIS LMC Major Business
Table 79. OASIS LMC AI Drug Safety Prediction Software Product and Solutions
Table 80. OASIS LMC AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. OASIS LMC Recent Developments and Future Plans
Table 82. Global AI Drug Safety Prediction Software Revenue (USD Million) by Players (2021-2026)
Table 83. Global AI Drug Safety Prediction Software Revenue Share by Players (2021-2026)
Table 84. Breakdown of AI Drug Safety Prediction Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 85. Market Position of Players in AI Drug Safety Prediction Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 86. Head Office of Key AI Drug Safety Prediction Software Players
Table 87. AI Drug Safety Prediction Software Market: Company Product Type Footprint
Table 88. AI Drug Safety Prediction Software Market: Company Product Application Footprint
Table 89. AI Drug Safety Prediction Software New Market Entrants and Barriers to Market Entry
Table 90. AI Drug Safety Prediction Software Mergers, Acquisition, Agreements, and Collaborations
Table 91. Global AI Drug Safety Prediction Software Consumption Value (USD Million) by Type (2021-2026)
Table 92. Global AI Drug Safety Prediction Software Consumption Value Share by Type (2021-2026)
Table 93. Global AI Drug Safety Prediction Software Consumption Value Forecast by Type (2027-2032)
Table 94. Global AI Drug Safety Prediction Software Consumption Value by Application (2021-2026)
Table 95. Global AI Drug Safety Prediction Software Consumption Value Forecast by Application (2027-2032)
Table 96. North America AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 97. North America AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 98. North America AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 99. North America AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 100. North America AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 101. North America AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Europe AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Europe AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Europe AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Europe AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Europe AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Europe AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 109. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 110. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 111. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 112. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 113. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2027-2032) & (USD Million)
Table 114. South America AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 115. South America AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 116. South America AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 117. South America AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 118. South America AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 119. South America AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 121. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 122. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Global Key Players of AI Drug Safety Prediction Software Upstream (Raw Materials)
Table 127. Global AI Drug Safety Prediction Software Typical Customers
Table 1. Global AI Drug Safety Prediction Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI Drug Safety Prediction Software Consumption Value by Deployment Model, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI Drug Safety Prediction Software Consumption Value by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI Drug Safety Prediction Software Consumption Value by Model Customization, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI Drug Safety Prediction Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Global AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 7. Global AI Drug Safety Prediction Software Consumption Value by Region (2027-2032) & (USD Million)
Table 8. Simulations Plus Company Information, Head Office, and Major Competitors
Table 9. Simulations Plus Major Business
Table 10. Simulations Plus AI Drug Safety Prediction Software Product and Solutions
Table 11. Simulations Plus AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 12. Simulations Plus Recent Developments and Future Plans
Table 13. Dassault Syst?mes Company Information, Head Office, and Major Competitors
Table 14. Dassault Syst?mes Major Business
Table 15. Dassault Syst?mes AI Drug Safety Prediction Software Product and Solutions
Table 16. Dassault Syst?mes AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 17. Dassault Syst?mes Recent Developments and Future Plans
Table 18. Schr?dinger Company Information, Head Office, and Major Competitors
Table 19. Schr?dinger Major Business
Table 20. Schr?dinger AI Drug Safety Prediction Software Product and Solutions
Table 21. Schr?dinger AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 22. Certara Company Information, Head Office, and Major Competitors
Table 23. Certara Major Business
Table 24. Certara AI Drug Safety Prediction Software Product and Solutions
Table 25. Certara AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 26. Certara Recent Developments and Future Plans
Table 27. Lhasa Limited Company Information, Head Office, and Major Competitors
Table 28. Lhasa Limited Major Business
Table 29. Lhasa Limited AI Drug Safety Prediction Software Product and Solutions
Table 30. Lhasa Limited AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 31. Lhasa Limited Recent Developments and Future Plans
Table 32. Instem Company Information, Head Office, and Major Competitors
Table 33. Instem Major Business
Table 34. Instem AI Drug Safety Prediction Software Product and Solutions
Table 35. Instem AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 36. Instem Recent Developments and Future Plans
Table 37. ACD/Labs Company Information, Head Office, and Major Competitors
Table 38. ACD/Labs Major Business
Table 39. ACD/Labs AI Drug Safety Prediction Software Product and Solutions
Table 40. ACD/Labs AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 41. ACD/Labs Recent Developments and Future Plans
Table 42. Chemical Computing Group Company Information, Head Office, and Major Competitors
Table 43. Chemical Computing Group Major Business
Table 44. Chemical Computing Group AI Drug Safety Prediction Software Product and Solutions
Table 45. Chemical Computing Group AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 46. Chemical Computing Group Recent Developments and Future Plans
Table 47. Optibrium Company Information, Head Office, and Major Competitors
Table 48. Optibrium Major Business
Table 49. Optibrium AI Drug Safety Prediction Software Product and Solutions
Table 50. Optibrium AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 51. Optibrium Recent Developments and Future Plans
Table 52. MultiCASE Company Information, Head Office, and Major Competitors
Table 53. MultiCASE Major Business
Table 54. MultiCASE AI Drug Safety Prediction Software Product and Solutions
Table 55. MultiCASE AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 56. MultiCASE Recent Developments and Future Plans
Table 57. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 58. Insilico Medicine Major Business
Table 59. Insilico Medicine AI Drug Safety Prediction Software Product and Solutions
Table 60. Insilico Medicine AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 61. Insilico Medicine Recent Developments and Future Plans
Table 62. MindRank Company Information, Head Office, and Major Competitors
Table 63. MindRank Major Business
Table 64. MindRank AI Drug Safety Prediction Software Product and Solutions
Table 65. MindRank AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 66. MindRank Recent Developments and Future Plans
Table 67. Molecular Discovery Company Information, Head Office, and Major Competitors
Table 68. Molecular Discovery Major Business
Table 69. Molecular Discovery AI Drug Safety Prediction Software Product and Solutions
Table 70. Molecular Discovery AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 71. Molecular Discovery Recent Developments and Future Plans
Table 72. Molecular Networks Company Information, Head Office, and Major Competitors
Table 73. Molecular Networks Major Business
Table 74. Molecular Networks AI Drug Safety Prediction Software Product and Solutions
Table 75. Molecular Networks AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 76. Molecular Networks Recent Developments and Future Plans
Table 77. OASIS LMC Company Information, Head Office, and Major Competitors
Table 78. OASIS LMC Major Business
Table 79. OASIS LMC AI Drug Safety Prediction Software Product and Solutions
Table 80. OASIS LMC AI Drug Safety Prediction Software Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 81. OASIS LMC Recent Developments and Future Plans
Table 82. Global AI Drug Safety Prediction Software Revenue (USD Million) by Players (2021-2026)
Table 83. Global AI Drug Safety Prediction Software Revenue Share by Players (2021-2026)
Table 84. Breakdown of AI Drug Safety Prediction Software by Company Type (Tier 1, Tier 2, and Tier 3)
Table 85. Market Position of Players in AI Drug Safety Prediction Software, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 86. Head Office of Key AI Drug Safety Prediction Software Players
Table 87. AI Drug Safety Prediction Software Market: Company Product Type Footprint
Table 88. AI Drug Safety Prediction Software Market: Company Product Application Footprint
Table 89. AI Drug Safety Prediction Software New Market Entrants and Barriers to Market Entry
Table 90. AI Drug Safety Prediction Software Mergers, Acquisition, Agreements, and Collaborations
Table 91. Global AI Drug Safety Prediction Software Consumption Value (USD Million) by Type (2021-2026)
Table 92. Global AI Drug Safety Prediction Software Consumption Value Share by Type (2021-2026)
Table 93. Global AI Drug Safety Prediction Software Consumption Value Forecast by Type (2027-2032)
Table 94. Global AI Drug Safety Prediction Software Consumption Value by Application (2021-2026)
Table 95. Global AI Drug Safety Prediction Software Consumption Value Forecast by Application (2027-2032)
Table 96. North America AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 97. North America AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 98. North America AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 99. North America AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 100. North America AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 101. North America AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 102. Europe AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 103. Europe AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 104. Europe AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 105. Europe AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 106. Europe AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Europe AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 109. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 110. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 111. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 112. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2021-2026) & (USD Million)
Table 113. Asia-Pacific AI Drug Safety Prediction Software Consumption Value by Region (2027-2032) & (USD Million)
Table 114. South America AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 115. South America AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 116. South America AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 117. South America AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 118. South America AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 119. South America AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 120. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2021-2026) & (USD Million)
Table 121. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Type (2027-2032) & (USD Million)
Table 122. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2021-2026) & (USD Million)
Table 123. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Application (2027-2032) & (USD Million)
Table 124. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2021-2026) & (USD Million)
Table 125. Middle East & Africa AI Drug Safety Prediction Software Consumption Value by Country (2027-2032) & (USD Million)
Table 126. Global Key Players of AI Drug Safety Prediction Software Upstream (Raw Materials)
Table 127. Global AI Drug Safety Prediction Software Typical Customers
LIST OF FIGURES
Figure 1. AI Drug Safety Prediction Software Picture
Figure 2. Global AI Drug Safety Prediction Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Drug Safety Prediction Software Consumption Value Market Share by Type in 2025
Figure 4. Integrated ADMET Prediction
Figure 5. Toxicity Endpoint Prediction
Figure 6. Drug-Drug Interaction and PK Safety Prediction
Figure 7. Metabolism and Metabolite Prediction
Figure 8. Off-Target and Safety Pharmacology Prediction
Figure 9. Global AI Drug Safety Prediction Software Consumption Value by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 10. Global AI Drug Safety Prediction Software Consumption Value Market Share by Deployment Model in 2025
Figure 11. Cloud-Based
Figure 12. On-Premises
Figure 13. Hybrid Deployment
Figure 14. Global AI Drug Safety Prediction Software Consumption Value by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Figure 15. Global AI Drug Safety Prediction Software Consumption Value Market Share by Modeling Approach in 2025
Figure 16. Machine Learning and Deep Learning
Figure 17. QSAR and Statistical Modeling
Figure 18. Knowledge-Based and Rule-Based
Figure 19. Physics-Based Simulation
Figure 20. Hybrid Modeling
Figure 21. Global AI Drug Safety Prediction Software Consumption Value by Model Customization, (USD Million), 2021 & 2025 & 2032
Figure 22. Global AI Drug Safety Prediction Software Consumption Value Market Share by Model Customization in 2025
Figure 23. Fixed Pretrained Models
Figure 24. User-Trained Models
Figure 25. Hybrid Model Platforms
Figure 26. Global AI Drug Safety Prediction Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 27. AI Drug Safety Prediction Software Consumption Value Market Share by Application in 2025
Figure 28. Hit and Lead Screening Picture
Figure 29. Lead Optimization Picture
Figure 30. Candidate Selection Picture
Figure 31. Preclinical Safety Assessment Picture
Figure 32. Regulatory Safety Assessment Picture
Figure 33. Other Drug Safety Research Picture
Figure 34. Global AI Drug Safety Prediction Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global AI Drug Safety Prediction Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Market AI Drug Safety Prediction Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 37. Global AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 38. Global AI Drug Safety Prediction Software Consumption Value Market Share by Region in 2025
Figure 39. North America AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 42. South America AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 44. Company Three Recent Developments and Future Plans
Figure 45. Global AI Drug Safety Prediction Software Revenue Share by Players in 2025
Figure 46. AI Drug Safety Prediction Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 47. Market Share of AI Drug Safety Prediction Software by Player Revenue in 2025
Figure 48. Top 3 AI Drug Safety Prediction Software Players Market Share in 2025
Figure 49. Top 6 AI Drug Safety Prediction Software Players Market Share in 2025
Figure 50. Global AI Drug Safety Prediction Software Consumption Value Share by Type (2021-2026)
Figure 51. Global AI Drug Safety Prediction Software Market Share Forecast by Type (2027-2032)
Figure 52. Global AI Drug Safety Prediction Software Consumption Value Share by Application (2021-2026)
Figure 53. Global AI Drug Safety Prediction Software Market Share Forecast by Application (2027-2032)
Figure 54. North America AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 55. North America AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 56. North America AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 57. United States AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 58. Canada AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 59. Mexico AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 60. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 61. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 62. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 63. Germany AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 64. France AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 65. United Kingdom AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 66. Russia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 67. Italy AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 68. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 69. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 70. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 71. China AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 74. India AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 77. South America AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 78. South America AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 79. South America AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 83. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 84. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 87. UAE AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 88. AI Drug Safety Prediction Software Market Drivers
Figure 89. AI Drug Safety Prediction Software Market Restraints
Figure 90. AI Drug Safety Prediction Software Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. AI Drug Safety Prediction Software Industrial Chain
Figure 93. Methodology
Figure 94. Research Process and Data Source
Figure 1. AI Drug Safety Prediction Software Picture
Figure 2. Global AI Drug Safety Prediction Software Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI Drug Safety Prediction Software Consumption Value Market Share by Type in 2025
Figure 4. Integrated ADMET Prediction
Figure 5. Toxicity Endpoint Prediction
Figure 6. Drug-Drug Interaction and PK Safety Prediction
Figure 7. Metabolism and Metabolite Prediction
Figure 8. Off-Target and Safety Pharmacology Prediction
Figure 9. Global AI Drug Safety Prediction Software Consumption Value by Deployment Model, (USD Million), 2021 & 2025 & 2032
Figure 10. Global AI Drug Safety Prediction Software Consumption Value Market Share by Deployment Model in 2025
Figure 11. Cloud-Based
Figure 12. On-Premises
Figure 13. Hybrid Deployment
Figure 14. Global AI Drug Safety Prediction Software Consumption Value by Modeling Approach, (USD Million), 2021 & 2025 & 2032
Figure 15. Global AI Drug Safety Prediction Software Consumption Value Market Share by Modeling Approach in 2025
Figure 16. Machine Learning and Deep Learning
Figure 17. QSAR and Statistical Modeling
Figure 18. Knowledge-Based and Rule-Based
Figure 19. Physics-Based Simulation
Figure 20. Hybrid Modeling
Figure 21. Global AI Drug Safety Prediction Software Consumption Value by Model Customization, (USD Million), 2021 & 2025 & 2032
Figure 22. Global AI Drug Safety Prediction Software Consumption Value Market Share by Model Customization in 2025
Figure 23. Fixed Pretrained Models
Figure 24. User-Trained Models
Figure 25. Hybrid Model Platforms
Figure 26. Global AI Drug Safety Prediction Software Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 27. AI Drug Safety Prediction Software Consumption Value Market Share by Application in 2025
Figure 28. Hit and Lead Screening Picture
Figure 29. Lead Optimization Picture
Figure 30. Candidate Selection Picture
Figure 31. Preclinical Safety Assessment Picture
Figure 32. Regulatory Safety Assessment Picture
Figure 33. Other Drug Safety Research Picture
Figure 34. Global AI Drug Safety Prediction Software Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 35. Global AI Drug Safety Prediction Software Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 36. Global Market AI Drug Safety Prediction Software Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 37. Global AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 38. Global AI Drug Safety Prediction Software Consumption Value Market Share by Region in 2025
Figure 39. North America AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 40. Europe AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 41. Asia-Pacific AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 42. South America AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 43. Middle East & Africa AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 44. Company Three Recent Developments and Future Plans
Figure 45. Global AI Drug Safety Prediction Software Revenue Share by Players in 2025
Figure 46. AI Drug Safety Prediction Software Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 47. Market Share of AI Drug Safety Prediction Software by Player Revenue in 2025
Figure 48. Top 3 AI Drug Safety Prediction Software Players Market Share in 2025
Figure 49. Top 6 AI Drug Safety Prediction Software Players Market Share in 2025
Figure 50. Global AI Drug Safety Prediction Software Consumption Value Share by Type (2021-2026)
Figure 51. Global AI Drug Safety Prediction Software Market Share Forecast by Type (2027-2032)
Figure 52. Global AI Drug Safety Prediction Software Consumption Value Share by Application (2021-2026)
Figure 53. Global AI Drug Safety Prediction Software Market Share Forecast by Application (2027-2032)
Figure 54. North America AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 55. North America AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 56. North America AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 57. United States AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 58. Canada AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 59. Mexico AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 60. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 61. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 62. Europe AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 63. Germany AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 64. France AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 65. United Kingdom AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 66. Russia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 67. Italy AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 68. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 69. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 70. Asia-Pacific AI Drug Safety Prediction Software Consumption Value Market Share by Region (2021-2032)
Figure 71. China AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 72. Japan AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 73. South Korea AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 74. India AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 75. Southeast Asia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 76. Australia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 77. South America AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 78. South America AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 79. South America AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 80. Brazil AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 81. Argentina AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 82. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Type (2021-2032)
Figure 83. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Application (2021-2032)
Figure 84. Middle East & Africa AI Drug Safety Prediction Software Consumption Value Market Share by Country (2021-2032)
Figure 85. Turkey AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 86. Saudi Arabia AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 87. UAE AI Drug Safety Prediction Software Consumption Value (2021-2032) & (USD Million)
Figure 88. AI Drug Safety Prediction Software Market Drivers
Figure 89. AI Drug Safety Prediction Software Market Restraints
Figure 90. AI Drug Safety Prediction Software Market Trends
Figure 91. Porters Five Forces Analysis
Figure 92. AI Drug Safety Prediction Software Industrial Chain
Figure 93. Methodology
Figure 94. Research Process and Data Source
